taxonomy (1)
protein (1)
source (4)
structure (52)
composition (50)
disease (3)
reference (4)
site (11)
peptide (10)
- Homo sapiens (Human)
Taxonomy
- Blood Serum (UBERON_0001977)
- Mammalian Vulva (UBERON_0000997) A-431 (CVCL_0037)
- Mammary Gland (UBERON_0001911)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
Source
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Fuc(a1-2)Gal(b1-4) + Gal(b1-4)"
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-?)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-?)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-?)[GlcNAc(b1-?)]Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Fuc(a1-2)Gal(b1-4)"
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-?)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4) + Gal(b1-4)"
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-?)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-?)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4) + Fuc(a1-2)Gal(b1-4)"
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-?)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-4)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Fuc(a1-3)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-?)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-?)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-4)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc + 2 x NeuAc(a2-3)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
Reported structure
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:6 dHex:2 (avg mass : 2178.0409 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 (avg mass : 2371.1942 )
- Hex:5 HexNAc:5 NeuAc:1 (avg mass : 2135.9602 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:2 (avg mass : 2136.9883 )
- Hex:5 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2428.2462 )
- Hex:5 HexNAc:5 dHex:3 (avg mass : 2283.1313 )
- Hex:5 HexNAc:5 dHex:3 NeuAc:1 (avg mass : 2574.3892 )
- Hex:5 HexNAc:6 dHex:2 (avg mass : 2340.1833 )
- Hex:5 HexNAc:6 dHex:3 (avg mass : 2486.3263 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:4 dHex:3 (avg mass : 2242.0787 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 (avg mass : 2299.1307 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 (avg mass : 2881.6465 )
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2938.6985 )
- Hex:6 HexNAc:6 dHex:2 (avg mass : 2502.3257 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:6 NeuAc:2 (avg mass : 2954.6979 )
- Hex:7 HexNAc:6 NeuAc:3 (avg mass : 3245.9558 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
- Hex:7 HexNAc:6 dHex:2 NeuAc:4 (avg mass : 3829.4997 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:8 HexNAc:7 dHex:1 NeuAc:4 (avg mass : 4048.6941 )
- Hex:8 HexNAc:7 dHex:2 NeuAc:4 (avg mass : 4194.8371 )
- Hex:8 HexNAc:7 dHex:3 NeuAc:4 (avg mass : 4340.9801 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Cancer, breast (DOID:1612)
- Carcinoma, Squamous cell (DOID:1749)
- Prostate cancer (DOID:10283)
Disease
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Characterisation of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor (2000 - Sato, Kim, Abe, Saito, Yokoyama, Kohda) / Status : Reviewed
- Characterization of the carbohydrate chains of the secreted form of the human epidermal growth factor receptor. (2000 - Stroop C, Weber W, Gerwig G, Nimtz M, Kamerling J, Vliegenthart J) / Status : Reviewed
Reference
- Epidermal growth factor receptor / Homo sapiens
Reported glycosite
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Carcinoma, Squamous cell (DOID:1749)
- Characterisation of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor (2000 - Sato, Kim, Abe, Saito, Yokoyama, Kohda) / Status : Reviewed
- Characterization of the carbohydrate chains of the secreted form of the human epidermal growth factor receptor. (2000 - Stroop C, Weber W, Gerwig G, Nimtz M, Kamerling J, Vliegenthart J) / Status : Reviewed
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Asn-56
-
- N-Linked / Complex
(avg mass : 1932.7652)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2006.8447)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Epidermal growth factor receptor / Homo sapiens
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2079.9363)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2136.9883)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2136.9883)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2136.9883)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2178.0409)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2224.0231)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2225.0512)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2225.0512)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2225.0512)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2282.1032)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2282.1032)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2283.1313)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2283.1313)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2299.1307)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2299.1307)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2340.1833)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2356.1827)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2356.1827)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2371.1942)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2371.1942)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2428.2462)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2428.2462)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2486.3263)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2502.3257)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2502.3257)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2516.3091)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2516.3091)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2574.3892)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3683.3567)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3829.4997)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3829.4997)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 4048.6941)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 4048.6941)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 4194.8371)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 4194.8371)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 4340.9801)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1235.1173)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / High-Mannose
(avg mass : 1397.2597)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / High-Mannose
(avg mass : 1559.4021)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / High-Mannose
(avg mass : 1559.4021)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- N-Linked / High-Mannose
(avg mass : 1721.5445)
- Carcinoma, Squamous cell (DOID:1749)
-
Epidermal growth factor receptor / Homo sapiens
- Undefined site
- Epidermal growth factor receptor / Homo sapiens
-
- Hex:5 HexNAc:2 / N-Linked
(avg mass : 1235.1173)
- Mammary Gland (UBERON_0001911)
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Cancer, breast (DOID:1612)
- Epidermal growth factor receptor / Homo sapiens
- DSISINATNIK (11aa)
-
- Hex:6 HexNAc:2 / N-Linked
(avg mass : 1397.2597)
- Mammary Gland (UBERON_0001911)
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Cancer, breast (DOID:1612)
- Epidermal growth factor receptor / Homo sapiens
- DSISINATNIK (11aa)
-
- Hex:3 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1463.3655)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Epidermal growth factor receptor / Homo sapiens
- CDPSCPNGSCWGAGEENCQK (20aa)
-
- Hex:7 HexNAc:2 / N-Linked
(avg mass : 1559.4021)
- Mammary Gland (UBERON_0001911)
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Cancer, breast (DOID:1612)
- Epidermal growth factor receptor / Homo sapiens
- DSISINATNIK (11aa)
- NCTSISGDLHILPVAFR (17aa)
-
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked
(avg mass : 1567.4278)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- DNIGSQYLLNWCVQIAK (17aa)
-
- Hex:4 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1625.5079)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Epidermal growth factor receptor / Homo sapiens
- CDPSCPNGSCWGAGEENCQK (20aa)
-
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
- Mammary Gland (UBERON_0001911)
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Cancer, breast (DOID:1612)
- Epidermal growth factor receptor / Homo sapiens
- DSISINATNIK (11aa)
-
- Hex:9 HexNAc:2 / N-Linked
(avg mass : 1883.6869)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Epidermal growth factor receptor / Homo sapiens
- DSISINATNIK (11aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 1932.7652)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- DIVSSDFLSNMSMDFQNHLGSCQK (24aa)
- DTCPPLMLYNPTTYQMDVNPEGK (23aa)
- NCTSISGDLHILPVAFR (17aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2078.9082)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- NLCYANTINWK (11aa)
- TCPAGVMGENNTLVWK (16aa)
- DNIGSQYLLNWCVQIAK (17aa)
-
- Hex:5 HexNAc:4 dHex:3 / N-Linked
(avg mass : 2079.9363)
- Mammary Gland (UBERON_0001911)
- N-Linked / Complex / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- Cancer, breast (DOID:1612)
- Epidermal growth factor receptor / Homo sapiens
- EITGFLLIQAWPENR (15aa)
-
- Hex:5 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2135.9602)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- DTCPPLMLYNPTTYQMDVNPEGK (23aa)
-
- Hex:6 HexNAc:6 / N-Linked
(avg mass : 2210.0397)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Epidermal growth factor receptor / Homo sapiens
- TCPAGVMGENNTLVWK (16aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked
(avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- MFNNCEVVLGNLEITYVQR (19aa)
- DTCPPLMLYNPTTYQMDVNPEGK (23aa)
- NCTSISGDLHILPVAFR (17aa)
- NLCYANTINWK (11aa)
- DNIGSQYLLNWCVQIAK (17aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2225.0512)
- Mammary Gland (UBERON_0001911)
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-?)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- Cancer, breast (DOID:1612)
- Epidermal growth factor receptor / Homo sapiens
- EITGFLLIQAWPENR (15aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2241.0506)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- NCTSISGDLHILPVAFR (17aa)
-
- Hex:6 HexNAc:4 dHex:3 / N-Linked
(avg mass : 2242.0787)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Epidermal growth factor receptor / Homo sapiens
- EITGFLLIQAWPENR (15aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- DTCPPLMLYNPTTYQMDVNPEGK (23aa)
-
- Hex:12 HexNAc:2 / N-Linked
(avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Epidermal growth factor receptor / Homo sapiens
- TCPAGVMGENNTLVWK (16aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2370.1661)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- TCPAGVMGENNTLVWK (16aa)
- DNIGSQYLLNWCVQIAK (17aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2444.2456)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- DNIGSQYLLNWCVQIAK (17aa)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked
(avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- DTCPPLMLYNPTTYQMDVNPEGK (23aa)
- NCTSISGDLHILPVAFR (17aa)
- DNIGSQYLLNWCVQIAK (17aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2735.5035)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- TCPAGVMGENNTLVWK (16aa)
- DNIGSQYLLNWCVQIAK (17aa)
-
- Hex:6 HexNAc:5 NeuAc:3 / N-Linked
(avg mass : 2880.6184)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- DTCPPLMLYNPTTYQMDVNPEGK (23aa)
- NCTSISGDLHILPVAFR (17aa)
- DNIGSQYLLNWCVQIAK (17aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 / N-Linked
(avg mass : 2881.6465)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- NLCYANTINWK (11aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2938.6985)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- DNIGSQYLLNWCVQIAK (17aa)
-
- Hex:7 HexNAc:6 NeuAc:2 / N-Linked
(avg mass : 2954.6979)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- DTCPPLMLYNPTTYQMDVNPEGK (23aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked
(avg mass : 3026.7614)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- DNIGSQYLLNWCVQIAK (17aa)
-
- Hex:7 HexNAc:6 NeuAc:3 / N-Linked
(avg mass : 3245.9558)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Epidermal growth factor receptor / Homo sapiens
- DTCPPLMLYNPTTYQMDVNPEGK (23aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 NeuAc:3 / N-Linked
(avg mass : 3245.9558)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked
(avg mass : 3026.7614)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 NeuAc:2 / N-Linked
(avg mass : 2954.6979)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2938.6985)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 / N-Linked
(avg mass : 2881.6465)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 NeuAc:3 / N-Linked
(avg mass : 2880.6184)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2735.5035)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked
(avg mass : 2589.3605)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2444.2456)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2370.1661)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:12 HexNAc:2 / N-Linked
(avg mass : 2370.1141)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2298.1026)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 dHex:3 / N-Linked
(avg mass : 2242.0787)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2241.0506)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2225.0512)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked
(avg mass : 2224.0231)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:6 / N-Linked
(avg mass : 2210.0397)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2135.9602)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:3 / N-Linked
(avg mass : 2079.9363)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2078.9082)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 1932.7652)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:9 HexNAc:2 / N-Linked
(avg mass : 1883.6869)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1625.5079)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked
(avg mass : 1567.4278)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:2 / N-Linked
(avg mass : 1559.4021)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1463.3655)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:2 / N-Linked
(avg mass : 1397.2597)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:2 / N-Linked
(avg mass : 1235.1173)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / High-Mannose
(avg mass : 1721.5445)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / High-Mannose
(avg mass : 1559.4021)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / High-Mannose
(avg mass : 1559.4021)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / High-Mannose
(avg mass : 1397.2597)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / High-Mannose
(avg mass : 1235.1173)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 4340.9801)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 4194.8371)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 4194.8371)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 4048.6941)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 4048.6941)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3829.4997)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3829.4997)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3683.3567)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2574.3892)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2516.3091)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2516.3091)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2502.3257)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2502.3257)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2486.3263)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2428.2462)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2428.2462)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2371.1942)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2371.1942)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2370.1661)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2356.1827)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2356.1827)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2340.1833)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2299.1307)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2299.1307)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2283.1313)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2283.1313)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2282.1032)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2282.1032)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2225.0512)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2225.0512)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2225.0512)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2224.0231)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2178.0409)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2136.9883)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2136.9883)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2136.9883)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2079.9363)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2006.8447)
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Disease
Reference
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1787.6503)